公开(公告)号：US20220213080A1

公开(公告)日：2022-07-07

申请号：US17525116

申请日：2021-11-12

申请人： HUSCION CO., LTD.

发明人： Seong Soo JOO ,  Nareum HA ,  Jungmin YU ,  Youngsoo GYOUNG ,  Jonggab JUN ,  Heonse JEONG ,  Sukil JANG

IPC分类号： C07D413/12 ,  A61K9/00 ,  A61P37/06 ,  C07D211/86 ,  C07D295/185 ,  C07D207/38 ,  C07C235/88 ,  C07C235/78 ,  C07D211/76 ,  C07D405/06 ,  A23L33/00 ,  A23L33/10

摘要： Disclosed are a novel piperlongumine-based compound, an immuno regulator containing as an active ingredient the compound, or a pharmaceutically acceptable salt or solvate thereof, and a health functional food for immune regulation.

公开(公告)号：US20240100031A1

公开(公告)日：2024-03-28

申请号：US18269398

申请日：2021-12-27

申请人： HUSCION CO., LTD.

发明人： Seong Soo JOO ,  Nareum HA ,  Jungmin YU ,  Youngsoo GYOUNG ,  Jonggab JUN ,  Heonse JEONG ,  Sukil JANG

IPC分类号： A61K31/4412 ,  A61K31/235 ,  A61K31/4015 ,  A61K31/4025 ,  A61K31/4439 ,  A61K31/495 ,  A61P31/14

CPC分类号： A61K31/4412 ,  A61K31/235 ,  A61K31/4015 ,  A61K31/4025 ,  A61K31/4439 ,  A61K31/495 ,  A61P31/14

摘要： The present disclosure relates to a pharmaceutical composition for preventing or treating viral infections, containing a piperlongumine-based compound as an active ingredient. Specifically, the piperlongumine-based compound according to the present disclosure inhibits SARS-CoV-2 infection, and thus can be useful for treating viral infections, particularly RNA viral infections.